NCT00189501View on ClinicalTrials.gov

A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 31, 2004

Conditions
Nephrology
Interventions
DRUG

Sensipar®

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY